ascnp - aeplan.co.jp · naoki nishiguchi toru nishikawa katsuji nishimura gentarou nishioka atsumi...

c/o A & E Planning Co., Ltd. Hitotsubashi Bekkan 4F, 2-4-4 Hitotsubashi, Chiyoda-ku, Tokyo 101-0003Tel: +81-3-3230-2744 Fax: +81-3-3230-2479 E-mail: [email protected]

Inquiries: AsCNP2019 SecretariatInquiries: AsCNP2019 SecretariatInquiries: AsCNP2019 Secretariat

AsCNP6th Congress of

Chair: Reiji Yoshimura(University of Occupational and Environmental Health)

Chair: Hisatsugu Miyata (Jikei University School of Medicine)

Chair: Reiji Yoshimura(University of Occupational and Environmental Health

29th Annual Meeting of Japanese Society of Clinical Neuropsychopharmacology

JSCNPChair: Chair: Hisatsugu Miyata Jikei University School of MedicineJikei University School of Medicine)University of Occupational and Environmental Health)

Chair: (Jikei University School of Medicine

Clinical Neuropsychopharmacology

49th Annual Meeting of Japanese Society of Neuropsychopharmacology

JSNPJoint Annual Meetings

Chair: Kazutaka Ikeda (Tokyo Metropolitan Institute of Medical Science)

Vice Chairs: Kazutaka Shimoda (Dokkyo Medical University)

Toshiyuki Someya (Niigata University)

Secretary: Shinya Kasai (Tokyo Metropolitan Institute of Medical Science)

October 11-13, 2019Fukuoka International Congress CenterFukuoka Sunpalace Hotel & HallFukuoka, Japan

Asian College of NeuropsychopharmacologyNeuropsychopharmacology to the next generation:

New wave from Asia

Late-breaking Abstract Submission: July 1(Mon) - 31(Wed), 2019

AsCNP2019 Websitehttps://www2.aeplan.co.jp/ascnp/

Greetings

It is our great pleasure to organize the 6th Asian College of Neuropsychopharmacology (AsCNP) Congress that will be held in Fukuoka, Japan, on October 11-13, 2019. The main theme of the congress is “Neuropsychopharmacology to the next generation: New wave from Asia.” Pharmacotherapy for the treatment of neuropsychiatric disorders should be developed further in Asia where robust economic expansion has occurred. Most medications for the treatment of central nervous system disorders have been developed for the European and American populations but are not always suitable for Asian populations. Medications should be developed specifically for Asians, including appropriate dosage and usage. The AsCNP2019 Congress seeks to advance neuropsychopharmacology to the next generation in Asia.

AsCNP was founded in 2008, based on the need to elucidate the mechanisms that underlie the effects of medications for the treatment of central nervous system disorders, develop new medications, and appropriately utilize such medications in Asia. The mission of AsCNP is to encourage research, facilitate the communication of ideas in converging disciplines of neuropsychopharmacology in Asia, develop pharmacotherapies for the treatment for psychiatric disorders, provide education and training opportunities, and empower patients and their families with scientific knowledge. The AsCNP Congress was convened in Kyoto in 2009, Seoul in 2011, Beijing in 2013, Taipei in 2015, and Bali in 2017. AsCNP currently has more than 3000 members.

The AsCNP2019 Congress will be held in conjunction with the annual meetings of the Japanese Society of Neuropsychopharmacology (JSNP) and Japanese Society of Clinical Neuropsychopharmacology (JSCNP). Other AsCNP member societies are also planning joint events at the AsCNP2019 Congress. Many scientists, clinicians, industry researchers, governmental officials, and invited world-renowned leaders will gather at the congress to advance neuropsychopharmacology in Asia.We look forward to welcoming you in Fukuoka in 2019.

Neuropsychopharmacology to the next generation:New wave from Asia

Congress Information

Period

6th Congress of Asian College of Neuropsychopharmacology (AsCNP2019)October 11 (Fri) – 13 (Sun), 2019

Joint Annual Meetings:29th Annual Meeting of Japanese Society of Clinical Neuropsychopharmacology (JSCNP2019)October 11 (Fri), 12 (Sat), 2019

49th Annual Meeting of Japanese Society of Neuropsychopharmacology (JSNP2019)October 12 (Sat), 13 (Sun), 2019

Venue

Fukuoka International Congress Center (2-1 Sekijo-machi, Hakata-ku, Fukuoka City 812-0032, TEL:092-262-4111)

Fukuoka Sunpalace Hotel and Hall(2-1, Chikko Hon-machi, Hakata-ku, Fukuoka City 812-0021, TEL: 092-272-1123)

Theme

Neuropsychopharmacology to the next generation: New wave from Asia

Expected Number of Participants

2,000 (total number of participants of the three meetings)

Host

Asian College of Neuropsychopharmacology (AsCNP)

Supporting Organizations

Fukuoka City / The International College of Neuropsychopharmacology / Japanese Association of Cardiovascular Pharmacology / Japan Epilepsy Society / Japanese Medical Society of Alcohol and Addiction Studies / The Japanese Neuropsychiatric Association / Japan Neuroscience Society / Japan Pharmaceutical Association / Japan Pharmaceutical Manufacturers Association / The Japanese Pharmacological Society / The Physiological Society of Japan / Japan Psychiatric Hospitals Association / The Japanese Society for Neurochemistry / Japanese Society of Biological Psychiatry / The Japanese Society of

6th Congress of Asian College of Neuropsychopharmacology (AsCNP2019) 1

Asian College of Neuropsychopharmacology

2 6th Congress of Asian College of Neuropsychopharmacology (AsCNP2019)

Clinical Pharmacology and Therapeutics / Japanese Society of Hospital Pharmacists / Japanese Society of General Hospital Psychiatry / Japanese Society of Neurology / Japanese Society of Mood Disorders / Japan Society of Pain Clinicians / Japanese Society for Psychiatric Diagnosis / The Japanese Society of Psychiatry and Neurology / Japanese Society of Schizophrenia Research / Japanese Society of Sleep Research / Japan Tourism Agency / The Kyushu Association of Neuropsychiatry / Kyushu Psychiatric Hospitals Association / The Molecular Biology Society of Japan / Union of Brain Science Associations in Japan

Organizers

Chair: Kazutaka Ikeda (Tokyo Metropolitan Institute of Medical Science)Vice Chairs: Kazutaka Shimoda (Dokkyo Medical University) Toshiyuki Someya (Niigata University)Alliance Head: Hiroyuki Uchida (Keio University) Secretary: Shinya Kasai (Tokyo Metropolitan Institute of Medical Science)

Organizing Committee Chair: Shigenobu Kanba (Kyushu Univeristy)Organizing Committee Members:

Tatsuo Akechi Satoshi Asakura Masato Asanuma Hazime Baba Won-Myong Bahk Ya-Mei Bai Haruhiko Bito Eric Yu Hai Chen Shigeru Chiba Lih-Chu Chiou Yuan-Hwa Chou Young-Chul Chung Brian Dean Nagafumi Doi Ken-ichi Fukuda Masato Fukuda Kohji Fukunaga Toshiaki A. Furukawa Tomoyuki Furuyashiki Hitoshi Hashimoto Kenji Hashimoto Ryota Hashimoto Nobutaka Hattori Yanling He Teruhiko Higuchi Hirokazu Hirai Masayuki Hiramatsu Yoshio Hirayasu Naoyuki Hironaka Hikaru Hori Jun Horiguchi Hiroshi Ichinose Jun-ichi Iga Kazutaka Ikeda Manabu Ikeda Masashi Ikeda Toshiya Inada Ataru Inagaki Koki Inoue Takeshi Inoue Masako Iseki Yasushi Ishida Kumiko Ishige Jun Ishigooka Takeshi Ishihara Masanari Itokawa Akira Iwanami Katsunori Iwasaki Nakao Iwata Nobuhisa Iwata Masaomi Iyo Hiroshi Kadotani Mitsuhiro Kamata Yasuhiro Kaneda Shuji Kaneko Kosuke Kanemoto Kiyoto Kasai Masaki Kato Nobumasa Kato Tadafumi Kato Chiaki Kawanishi Hiroaki Kawasaki Satoshi Kida Tetsuro Kikuchi Toshiaki Kikuchi Chan-Hyung Kim Euitae Kim Toshihiko Kinoshita Taro Kishi Taishiro Kishimoto Toshifumi Kishimoto Kiyoyuki Kitaichi Kazuto Kobayashi Fumitoshi Kodaka Tsuyoshi Koide Shuichi Koizumi Tsuyoshi Kondo Tsukasa Koyama Hiroaki Kumano Hiroshi Kunugi Toshihide Kuroki Ichiro Kusumi Jun Soo Kwon Shih-Ku Lin Tetsuya Matsuda Kenji Matsumoto Hisato Matsunaga Kazuo Mihara Roumen Milev Masaru Mimura Kyung Joon Min Masabumi Minami Itaru Miura Masatomo Miura Tsuyoshi Miyakawa Hitoshi Miyaoka



Hisatsugu Miyata Hirokazu Mizoguchi Akira Monji Hisashi Mori Shigeru Morinobu Norimitsu Morioka Toshiya Murai Mitsukuni Murasaki Hiroshi Nagase Shin Nakagawa Kazuyuki Nakagome Jun Nakamura Yu Nakamura Yoshihiro Nakata Minoru Narita Akinori Nishi Naoki Nishiguchi Toru Nishikawa Katsuji Nishimura Gentarou Nishioka Atsumi Nitta Shin-Ichi Niwa Yukihiro Noda Yasuyuki Nomura Shusuke Numata Tetsuro Ohmori Yukihiro Ohno Toshihisa Ohtsuka Motohiro Okada Hitoshi Okamoto Yasumasa Okamoto Hitoshi Okazawa Yoshiro Okubo Gaku Okugawa Hisae Ono Noriko Osumi Koichi Otani Kyohei Otani Tempei Otsubo Kotaro Otsuka Norio Ozaki Hiroki Ozawa Yuji Ozeki Naren P. Rao Tadashi Saigusa Manabu Saito Takuya Saito Toshikazu Saito Akira Sano Junji Saruwatari Masashi Sasa Masamichi Sato Mitsumoto Sato Yasushi Sato Winston W. Shen Eiji Shimizu Kazutaka Shimoda Takahiro Shinkai Kazuhiro Shinosaki Osamu Shirakawa Yukihiko Shirayama Tianme Si Toshiyuki Someya Ichiro Sora Tung-Ping Su Shiro Suda Norio Sugawara Tetsuya Suhara Tomiki Sumiyoshi Suresh Sundram Akihito Suzuki Michio Suzuki Takefumi Suzuki Tsutomu Suzuki Yutaro Suzuki Kohji Takada Hiroyuki Takagi Kazuo Takahama Hidehiko Takahashi Ryosuke Takahashi Masatoshi Takeda Yoshiteru Takekita Kazuhiro Takuma Toru Takumi Chay Hoon Tan Andi Jayalangkara Tanra Takeshi Terao Shogo Tokuyama Hiroaki Tomita Tetsu Tomita Makoto Tsuda Hiroyuki Uchida Naohisa Uchimura Yosuke Uchitomi Shu-ichi Ueno Yasuhito Uezono Koichiro Watanabe Norio Watanabe Shigeru Watanabe Takashi Watanabe Hirooki Yabe Kazuo Yamada Kiyofumi Yamada Mitsuhiko Yamada Norihito Yamada Shigeki Yamaguchi Hidenori Yamasue Shigeto Yamawaki Kazuhiko Yanai Yen-Kung Yang Norio Yasui-Furukori Setsuko Yasukawa Hiroshi Yoneda Yukio Yoneda Takeo Yoshikawa Masafumi Yoshimura Reiji Yoshimura Takashi Yoshio Mitsuhiro Yoshioka Xin Yu Kunio Yui Gang Zhu

Program Committee Chair: Ryota Hashimoto (National Center of Neurology and Psychiatry)Program Committee Members:

Kazutaka Ikeda Shinya Kasai Chan-Hyung Kim Fumitoshi Kodaka Shih-Ku Lin Roumen Milev Tsuyoshi Miyakawa Hisatsugu Miyata Tetsuo Nakabayashi Atsumi Nitta Naren P. Rao Kazutaka Shimoda Takahiro Shinkai Toshiyuki Someya Tung-Ping Su Suresh Sundram Chay Hoon Tan Andi Jayalangkara Tanra Hiroyuki Uchida Shigeto Yamawaki Reiji Yoshimura Xin Yu


Special LectureAsCNP Special Lecture

October 11 (Fri) 15 : 20 ~ 16 : 20Masayo TadaSumitomo Dainippon Pharma Co., Ltd.

October 12 (Sat) 8 : 40 ~ 10 : 20Allan Young Lakshmi YathamKing’s College London UK

University of British Columbia Canada

October 12 (Sat) 13 : 40 ~ 14 : 40George F. KoobNational Institute on Alcohol Abuse and AlcoholismUSA

October 13 (Sun) 13 : 40 ~ 14 : 40Hailan HuZhejiang University School of Medicine China

October 13 (Sun) 14 : 50 ~ 16 : 30John M. Kane Herbert Y. MeltzerThe Zucker Hillside Hospital USA

Northwestern Feinberg School of Medicine USA




JSNP/JSCNP Special Lecture

October 12 (Sat) 13 : 40 ~ 14 : 40Shigenobu KanbaKyushu UniversityJapan

※ Japanese Session

JSNP Special Lecture

October 13 (Sun) 13 : 40 ~ 14 : 40Edward F. DominoUniversity of MichiganUSA

JSCNP Special Lecture

October 11 (Fri) 15 : 20 ~ 16 : 20Toshiyuki SomeyaNiigata University Japan

※ Japanese Session

October 11 (Fri) 16 : 30 ~ 18 : 10Bernhard T. Baune Andrea FagioliniUniversity of MünsterGermany

University of Siena School of MedicineItaly


Day1: October 11 (Fri) *Tentative Schedule as of July, 2019

Building Congress Center Congress Center Fukuoka Sunpalace Hotel and Hall Congress Center BuildingFloor 3F 4F 4F 5F 2F 2F FloorVenue Room1 Room2 Room3 Room4 Room5 Room6 Room7 Room8 Room9 Room10 Room11 Room12 Room13 Room14 Room15 Room16 Room17 Poster Session VenueRoom Main Hall 411+412 413+414 409 410 401+402 403 404 405 406 502 503 501 Palace Room A Palace Room B Heian Suehiro Multipurpose Hall Room8:00

Opening Ceremony

Set Up

8:00

Maintenance treatment following remitted

�rst episode psychosis

Yu-Hai, Eric Chen

JSCNPSymposium

JSCNPSymposium

JSCNPSymposium

JSCNPSymposium

Developing new pharmaceutical

agents for unmet medical needs in schizophrenia - From preclinical

to clinical studiesWen-Sung Lai

JSCNPSymposium

JSCNPSymposium

JSCNPOral Presentation


A cutting-edge view on how to

regulate the drug dependence

related behaviors

Tomohisa Mori

Neurobiology of endocannabinoid

system in psychiatric disorders

Hiroki Ishiguro

Recent Advances in Autism

Research from Asia

Atsushi Sato

Novel treatment strategies based on the

advanced understanding of neurobiological

mechanisms in obsessive-compulsive

spectrum disorderHisato

Matsunaga

What can we learn from brain imaging studies

of schizophrenia? From its

pathophysiology to actual treatment Hiroyuki Uchida

Cellular and molecular signatures of

psychiatric disorders in postmortem human brainShinya Kasai

AsCNPOral Presentation

9:00 9:00

10:00 10:00

Translation of Research to Clinical Practice

Roumen Milev

JSCNPSymposium

JSCNPSymposium

JSCNPSymposium

JSCNPSymposium

Novel antidepressant targets found

from the central serotonergic and related systems

Mitsuhiro Yoshioka

The multidimensional

approach to metabolic

disturbance in schizophrenia

Mong-Liang Lu




Community Care and Global Mental Health:

innovative psychiatric

pharmacotherapy strategies in Asia

Chieko Kurihara

The Global Collection Initiative

for psychiatric genetics From

genetic variation to disease

mechanismsYasue Horiuchi

Novel strategy to treat hallucinations and

delusions in schizophrenia: searching for new targets

in neural circuits and brain networks

Kazuyuki Nakagome

Sponsored Symposium

Eisai Co., Ltd.

Stresses and psychiatric diseases ～mechanisms,

gender, treatment～Atsumi Nitta


Poster Exhibition

11:00 11:00

12:00 12:00

Luncheon Seminar

H. Lundbeck

Luncheon SeminarOtsuka

Pharmaceutical Co., Ltd.

Luncheon SeminarDaiichi Sankyo

Co., Ltd. / UCB Japan Co. Ltd.

Luncheon SeminarSumitomo Dainippon

Pharma Co., Ltd.

Luncheon SeminarMitsubishi

Tanabe Pharma Corporation.

13:00 13:00

JSCNP Award Lecture

Poster Discussion

14:00 14:00

JSCNP General Assembly & Council Committee15:00 15:00

Set up for Social Gathering

16:00 16:00


Speaker: Bernhard T.

Baune Andrea Fagiolini

Chair: Reiji Yoshimura

Sponsored Symposium

Janssen Pharmaceutical

K.K.

JSCNPSymposium

JSCNPSymposium

Sponsored SymposiumSHIONOGI &

CO., LTD. / Takeda

Pharmaceutical Company Limited.

Clinical research of gut-

microbiota-brain axis

Chun-Hsin Chen

Advances in animal

models of drug addiction

Soichiro Ide




Sponsored Symposium

Otsuka Pharmaceutical

Co., Ltd.

Future Development of Biomarker

in Mental disorders

Andi Jayalangkara

Tanra

International neuroimaging

big data collaborations:

ENIGMA and COCORO

Ryota Hashimoto

17:00 17:00

18:00 18:00

AsCNP/JSNP/JSCNP

Joint SocialGathering

19:00 19:00

20:00 20:00

AsCNP Special Lecture

Speaker: Masayo Tada Chair: Jun Soo Kwon

Program at a Glance

E J J J J E J J J

E

E

J

J

E

E

J J

J

J

J

J

J

J

E E J

J

J

JE E

8:40

10:20

12:10

15:20

16:20

18:10

12:30 12:30

13:30 13:30



Opening Ceremony

Set Up

8:00

Maintenance treatment following remitted

�rst episode psychosis

Yu-Hai, Eric Chen

JSCNPSymposium

JSCNPSymposium

JSCNPSymposium

JSCNPSymposium

Developing new pharmaceutical

agents for unmet medical needs in schizophrenia - From preclinical

to clinical studiesWen-Sung Lai

JSCNPSymposium

JSCNPSymposium



A cutting-edge view on how to

regulate the drug dependence

related behaviors

Tomohisa Mori

Neurobiology of endocannabinoid

system in psychiatric disorders

Hiroki Ishiguro

Recent Advances in Autism

Research from Asia

Atsushi Sato

Novel treatment strategies based on the

advanced understanding of neurobiological

mechanisms in obsessive-compulsive

spectrum disorderHisato

Matsunaga

What can we learn from brain imaging studies

of schizophrenia? From its

pathophysiology to actual treatment Hiroyuki Uchida

Cellular and molecular signatures of

psychiatric disorders in postmortem human brainShinya Kasai


9:00 9:00

10:00 10:00

Translation of Research to Clinical Practice

Roumen Milev

JSCNPSymposium

JSCNPSymposium

JSCNPSymposium

JSCNPSymposium

Novel antidepressant targets found

from the central serotonergic and related systems

Mitsuhiro Yoshioka


approach to metabolic

disturbance in schizophrenia

Mong-Liang Lu




Community Care and Global Mental Health:

innovative psychiatric

pharmacotherapy strategies in Asia

Chieko Kurihara

The Global Collection Initiative

for psychiatric genetics From

genetic variation to disease

mechanismsYasue Horiuchi

Novel strategy to treat hallucinations and

delusions in schizophrenia: searching for new targets

in neural circuits and brain networks

Kazuyuki Nakagome

Sponsored Symposium

Eisai Co., Ltd.

Stresses and psychiatric diseases ～mechanisms,

gender, treatment～Atsumi Nitta


Poster Exhibition

11:00 11:00

12:00 12:00

Luncheon Seminar

H. Lundbeck


Pharmaceutical Co., Ltd.

Luncheon SeminarDaiichi Sankyo

Co., Ltd. / UCB Japan Co. Ltd.


Pharma Co., Ltd.

Luncheon SeminarMitsubishi

Tanabe Pharma Corporation.

13:00 13:00

JSCNP Award Lecture

Poster Discussion

14:00 14:00

JSCNP General Assembly & Council Committee15:00 15:00

Set up for Social Gathering

16:00 16:00


Speaker: Bernhard T.

Baune Andrea Fagiolini

Chair: Reiji Yoshimura

Sponsored Symposium


K.K.

JSCNPSymposium

JSCNPSymposium

Sponsored SymposiumSHIONOGI &

CO., LTD. / Takeda

Pharmaceutical Company Limited.

Clinical research of gut-

microbiota-brain axis

Chun-Hsin Chen

Advances in animal

models of drug addiction

Soichiro Ide




Sponsored Symposium


Co., Ltd.

Future Development of Biomarker

in Mental disorders

Andi Jayalangkara

Tanra

International neuroimaging

big data collaborations:

ENIGMA and COCORO

Ryota Hashimoto

17:00 17:00

18:00 18:00

AsCNP/JSNP/JSCNP

Joint SocialGathering

19:00 19:00

20:00 20:00

The di�erent e�ects of ketamine and its enantiomers

on chronic stress induced- depressed animal models and

clinical antidepressant and anti-suicidal e�ect studies in acute and maintenance therapy of patients with

treatment resistant depressionTung-Ping Su Luncheon Seminar

Pfizer Japan Inc. / Sumitomo Dainippon Pharma Co., Ltd.

JSCNPSpecial Lecture

Speaker: Toshiyuki Someya Chair: Tsuyoshi Kondo

AsCNP Session JSNP/JSCNP Session JSNP Session JSCNP Session Sponsored Session

J : Japanese E : English

J E E E E E E E

J

J

J

E JJ

J

J

E

E

E E E E E E

E E

12:30

13:3013:40

14:30

15:10 15:10

18:20

15:20

16:20

13:40


Day2: October 12 (Sat)Building Congress Center Congress Center Fukuoka Sunpalace Hotel and Hall Congress Center BuildingFloor 3F 4F 4F 5F 2F 2F FloorVenue Room1 Room2 Room3 Room4 Room5 Room6 Room7 Room8 Room9 Room10 Room11 Room12 Room13 Room14 Room15 Room16 Room17 Poster Session VenueRoom Main Hall 411+412 413+414 409 410 401+402 403 404 405 406 502 503 501 Palace Room A Palace Room B Heian Suehiro Multipurpose Hall Room8:00

Set Up

8:00

AsCNPSpecial Lecture

Speaker: Allan Young

Lakshmi Yatham

JSNP-JSCNP Joint Workshop

JSNP-JSCNP Joint Symposium

JSNPSymposium

JSCNPSymposium

Translational Research for

New Drug Development in Neuropsychiatric

DisordersToshitaka

Nabeshima

JSCNPSymposium

JSNPOral

PresentationJSCNP

SymposiumJSCNP

Oral Presentation

Molecular Pathology and

Therapeutic Potentials in

SchizophreniaTetsuro Ohmori

Perspectives on psychiatric research from

an Asian-Paci�c context

Suresh Sundram

Sponsored Symposium

Philip Morris Japan Ltd. / Japan

Tobacco Inc. / British American

Tobacco Japan, Ltd.

Brain Stimulation on

Neuropsychiatric Disorders: Basic

Mechanisms and Clinical E�cacyCheng-Ta Li

Early detection and new intervention in

psychiatric disorders: from rare diseases, schizophrenia, to

dementiaNorio Ozaki

Imaging genetics of

schizophreniaJinsong Tang

AsCNPOral

Presentation

9:00 9:00

10:00 10:00

Regulatory Collaboration to Accelerate

Drug Development

Junko Sato Tetsuo

Nakabayashi

JSCNP SeminarJSNP-

JSCNP Joint Symposium

JSNPSymposium

JSCNPSymposium

Sponsored Symposium


Co., Ltd.

JSNPSymposium

JSNPOral

Presentation

JSCNPOral

Presentation

JSCNPOral

Presentation

Sponsored Symposium

Chugai Pharmaceutical

Co., Ltd.

The habenular nuclei involved

in emotional regulation

Hitoshi Hashimoto

Sponsored SymposiumSumitomo Dainippon

Pharma Co., Ltd.

Research on Asian

Psychotropic prescription

pattern (REAP)Shih-Ku Lin

Network meta-analysis, Individual

participant (network) meta-analysis & Cumulative

(network) meta-analysis

Toshi Furukawa

Glia-Psycho-Pathology:

Findings from Rodent Models

to Human Subjects

Takahiro Kato

Neuropsychopharmacology of relaxin-3

Gavin Stewart Dawe

Poster Exhibition

11:00 11:00

12:00 12:00


Pharma Co., Ltd


Pharmaceutical Co., Ltd

Luncheon SeminarEli Lilly Japan

K.K. / SHIONOGI & CO., LTD.

Luncheon SeminarTeijin Pharma

Limited.

Luncheon SeminarNippon

Shinyaku Co., Ltd.

Luncheon SeminarPhilip Morris

Japan Ltd.

Luncheon SeminarEisai Co., Ltd.

Luncheon SeminarH. Lundbeck13:00 13:00


Speaker: George F. Koob

14:00 14:00

AsCNP/AMEDSymposium

Makoto Suematsu

Shigeo OkabeJSCNP Seminar


JSNPSymposium

JSNPSymposium

Early Career Researchers Symposium

Clinical research in progress

on addictive medicine

Toshikazu Saito

JSNPSymposium

JSNPSymposium

JSCNPOral

Presentation

JSCNPOral

Presentation

Obsessive-compulsive

disorder: clinical heterogeneity and innovative

treatment approaches

Chan-Hyung Kim

Unveiling the neuro-cognitive underpinnings

of schizophrenia: From clinical

application to conceptual analysis

Yen-Kuang Yang

Ketamine: From Abused

Drug to Rapid-Acting

AntidepressantKenji

Hashimoto

Emerging roles of DAMPs/alarmins

and PRRs in neurological

disordersAtsufumi Kawabata

Understanding the pathophysiology of

psychiatric disorders: Japan / Australia

collaborations using tissue from the

Melbourne Brain Bank Brian Dean

AsCNPOral

Presentation

AsCNPOral

Presentation

15:00 15:00

16:00 16:00

PosterDiscussion

17:00 17:00

18:00 18:00

Evening Mixer with

Cheese & Wine

19:00 19:00

20:00 20:00

E J J J J E J J J

E

E

J

J

E

J

J

J

J

J

J

J

J

E

JJ

J

J

J

J

J

J

8:40

10:20

12:10

J

E

14:50

16:50

14:40

13:40

12:30

13:30



Set Up

8:00


Speaker: Allan Young

Lakshmi Yatham

JSNP-JSCNP Joint Workshop


JSNPSymposium

JSCNPSymposium

Translational Research for

New Drug Development in Neuropsychiatric

DisordersToshitaka

Nabeshima

JSCNPSymposium

JSNPOral

PresentationJSCNP

SymposiumJSCNP

Oral Presentation

Molecular Pathology and

Therapeutic Potentials in

SchizophreniaTetsuro Ohmori

Perspectives on psychiatric research from

an Asian-Paci�c context

Suresh Sundram

Sponsored Symposium

Philip Morris Japan Ltd. / Japan

Tobacco Inc. / British American

Tobacco Japan, Ltd.

Brain Stimulation on

Neuropsychiatric Disorders: Basic

Mechanisms and Clinical E�cacyCheng-Ta Li

Early detection and new intervention in

psychiatric disorders: from rare diseases, schizophrenia, to

dementiaNorio Ozaki

Imaging genetics of

schizophreniaJinsong Tang

AsCNPOral

Presentation

9:00 9:00

10:00 10:00

Regulatory Collaboration to Accelerate

Drug Development

Junko Sato Tetsuo

Nakabayashi

JSCNP SeminarJSNP-

JSCNP Joint Symposium

JSNPSymposium

JSCNPSymposium

Sponsored Symposium


Co., Ltd.

JSNPSymposium

JSNPOral

Presentation

JSCNPOral

Presentation

JSCNPOral

Presentation

Sponsored Symposium

Chugai Pharmaceutical

Co., Ltd.

The habenular nuclei involved

in emotional regulation

Hitoshi Hashimoto

Sponsored SymposiumSumitomo Dainippon

Pharma Co., Ltd.

Research on Asian

Psychotropic prescription

pattern (REAP)Shih-Ku Lin

Network meta-analysis, Individual

participant (network) meta-analysis & Cumulative

(network) meta-analysis

Toshi Furukawa

Glia-Psycho-Pathology:

Findings from Rodent Models

to Human Subjects

Takahiro Kato

Neuropsychopharmacology of relaxin-3

Gavin Stewart Dawe

Poster Exhibition

11:00 11:00

12:00 12:00


Pharma Co., Ltd


Pharmaceutical Co., Ltd

Luncheon SeminarEli Lilly Japan

K.K. / SHIONOGI & CO., LTD.

Luncheon SeminarTeijin Pharma

Limited.

Luncheon SeminarNippon

Shinyaku Co., Ltd.

Luncheon SeminarPhilip Morris

Japan Ltd.

Luncheon SeminarEisai Co., Ltd.

Luncheon SeminarH. Lundbeck13:00 13:00


Speaker: George F. Koob

14:00 14:00

AsCNP/AMEDSymposium

Makoto Suematsu

Shigeo OkabeJSCNP Seminar


JSNPSymposium

JSNPSymposium

Early Career Researchers Symposium

Clinical research in progress

on addictive medicine

Toshikazu Saito

JSNPSymposium

JSNPSymposium

JSCNPOral

Presentation

JSCNPOral

Presentation

Obsessive-compulsive

disorder: clinical heterogeneity and innovative

treatment approaches

Chan-Hyung Kim

Unveiling the neuro-cognitive underpinnings

of schizophrenia: From clinical

application to conceptual analysis

Yen-Kuang Yang

Ketamine: From Abused

Drug to Rapid-Acting

AntidepressantKenji

Hashimoto

Emerging roles of DAMPs/alarmins

and PRRs in neurological

disordersAtsufumi Kawabata

Understanding the pathophysiology of

psychiatric disorders: Japan / Australia

collaborations using tissue from the

Melbourne Brain Bank Brian Dean

AsCNPOral

Presentation

AsCNPOral

Presentation

15:00 15:00

16:00 16:00

PosterDiscussion

17:00 17:00

18:00 18:00

Evening Mixer with

Cheese & Wine

19:00 19:00

20:00 20:00

JSNP-JSCNP Joint sessionSpecial Lecture

Speaker: Shigenobu Kanba Chairs: Hisatsugu Miyata

Reiji Yoshimura

Luncheon SeminarKYOWA Pharmaceutical

Industry Co., Ltd. / Yoshitomiyakuhin

Corporation



J E E E E E E E

J

J

E

E

J

E

E

E

E

E

E

E

E

E

E

E

E

E

E

E

J

12:30

13:40

12:30

16:40

18:10

13:30

14:40

13:30


Day3: October 13 (Sun)Building Congress Center Congress Center Fukuoka Sunpalace Hotel and Hall Congress Center BuildingFloor 3F 4F 4F 5F 2F 2F FloorVenue Room1 Room2 Room3 Room4 Room5 Room6 Room7 Room8 Room9 Room10 Room11 Room12 Room13 Room14 Room15 Room16 Room17 Poster Session VenueRoom Main Hall 411+412 413+414 409 410 401+402 403 404 405 406 502 503 501 Palace Room A Palace Room B Heian Suehiro Multipurpose Hall Room8:00

Set Up

8:00

JSNP General Assembly

Noteworthy drug discovery/

research and development - Aiming for innovation -

Tetsurou Kikuchi

JSNPSymposium

EGUIDE workshop

Cognitive impairments,

neuroimaging and genetics in chronic methamphetamine users and ketamine

usersYanhui Liao

New development of

Research in Asian Psychotropic

Drug Prescription

(REAP)ChayHoon Tan


approach to treatment

response in major depression

Po-Hsiu Kuo

JSNPSymposium

JSNPSymposium

JSNPSymposium

JSNPSymposium

JSNPSymposium

Sponsored Symposium

Japan Tobacco Inc.

Dementia-In�ammation

and PropagationTetsuaki Arai

Translational Research regarding

pharmacological treatment of

ADHD Masanori Isobe

AsCNPAward Lecture

9:00 9:00

10:00 10:00

JSNP Seminar

CINP Symposium - Current and future

management of major depressive

disorder: challenges and perspectives -

Siegfried Kasper

Sponsored Symposium


K.K.

Psychostimulant Addiction and

Psychosis: Human Brain Imaging and

Rodent StudiesJin-Chung

Chen

Basic and Translational Research in

EpilepsyZhong Chen

Neuroimmune Mechanisms of Mood Disorder: A Translational

PerspectivePo See Chen

JSNPSymposium

JSNPSymposium

AsCNPOral Session

AsCNPAward Lecture

JSNPSymposium

Sponsored Symposium

Japan Tobacco Inc.

New frontier of bio-

markers and therapeutics in

DementiaKohji

Fukunaga

JSNPSymposium

Multifaceted Roles of Orexins:

Sleep, Pain and Reward Regulations

Lih-Chu Chiou

Poster Exhibition

11:00 11:00

12:00 12:00

Luncheon SeminarMeiji Seika

Pharma Co., Ltd.

Luncheon SeminarAstellas

Pharma Inc.13:00 13:00


Speaker: Hailan Hu

JSNPSpecial Lecture

Speaker: Edward F. Domino

14:00 14:00


Speaker: John M. Kane

Herbert Y Meltzer

JSNPSymposium

New vistas on monoamine

contributions to learning and

memorySatoshi Kida

Rethinking of E�ectiveness of

Clozapine Treatment for Treatment-

Refractory Schizophrenia Hidehiro

Oshibuchi

The aging e�ects on the brain,

cognition, and cardiovascular

system of pateints with severe

mental illnessShang-ying Tsai

JSNPSymposium

JSNPSymposium

JSNPSymposium

JSNPSymposium

JSNPSymposium

JSNPSymposium

Planning and conducting large pragmatic trials in psychiatry: for e�ective

discovery, dissemination and implementation of

evidence-based practicesMitsuhiko

Yamada

Toward a new era of precision

medicine for Parkinson's

diseaseNobutaka

Hattori

Asian Consortium

on MRI studies in Psychosis

projectKiyoto Kasai

Clinical Experience and Researches of Adult ADHD in

KoreaDuk-In Jon

Epignetic mechanisms underlying psychiatric disordersMakoto

Taniguchi

15:00 15:00

16:00 16:00

PosterDiscussion

17:00 17:00

18:00 18:00

Closing Ceremony

with Farewell Party

19:00 19:00

20:00 20:00

Luncheon Seminar SHIONOGI & CO., LTD. / Takeda Pharmaceutical

Company Limited

E J J E E E J J J

E J

J

E E E E

J

J J

8:40

10:20

12:10

E

E

J E E E J J J14:5014:40

13:40

12:3012:30

13:3013:30



Set Up

8:00

JSNP General Assembly

Noteworthy drug discovery/

research and development - Aiming for innovation -

Tetsurou Kikuchi

JSNPSymposium

EGUIDE workshop

Cognitive impairments,

neuroimaging and genetics in chronic methamphetamine users and ketamine

usersYanhui Liao

New development of

Research in Asian Psychotropic

Drug Prescription

(REAP)ChayHoon Tan


approach to treatment

response in major depression

Po-Hsiu Kuo

JSNPSymposium

JSNPSymposium

JSNPSymposium

JSNPSymposium

JSNPSymposium

Sponsored Symposium

Japan Tobacco Inc.

Dementia-In�ammation

and PropagationTetsuaki Arai

Translational Research regarding

pharmacological treatment of

ADHD Masanori Isobe

AsCNPAward Lecture

9:00 9:00

10:00 10:00

JSNP Seminar

CINP Symposium - Current and future

management of major depressive

disorder: challenges and perspectives -

Siegfried Kasper

Sponsored Symposium


K.K.

Psychostimulant Addiction and

Psychosis: Human Brain Imaging and

Rodent StudiesJin-Chung

Chen

Basic and Translational Research in

EpilepsyZhong Chen

Neuroimmune Mechanisms of Mood Disorder: A Translational

PerspectivePo See Chen

JSNPSymposium

JSNPSymposium

AsCNPOral Session

AsCNPAward Lecture

JSNPSymposium

Sponsored Symposium

Japan Tobacco Inc.

New frontier of bio-

markers and therapeutics in

DementiaKohji

Fukunaga

JSNPSymposium

Multifaceted Roles of Orexins:

Sleep, Pain and Reward Regulations

Lih-Chu Chiou

Poster Exhibition

11:00 11:00

12:00 12:00

Luncheon SeminarMeiji Seika

Pharma Co., Ltd.

Luncheon SeminarAstellas

Pharma Inc.13:00 13:00


Speaker: Hailan Hu

JSNPSpecial Lecture

Speaker: Edward F. Domino

14:00 14:00


Speaker: John M. Kane

Herbert Y Meltzer

JSNPSymposium

New vistas on monoamine

contributions to learning and

memorySatoshi Kida

Rethinking of E�ectiveness of

Clozapine Treatment for Treatment-

Refractory Schizophrenia Hidehiro

Oshibuchi

The aging e�ects on the brain,

cognition, and cardiovascular

system of pateints with severe

mental illnessShang-ying Tsai

JSNPSymposium

JSNPSymposium

JSNPSymposium

JSNPSymposium

JSNPSymposium

JSNPSymposium

Planning and conducting large pragmatic trials in psychiatry: for e�ective

discovery, dissemination and implementation of

evidence-based practicesMitsuhiko

Yamada

Toward a new era of precision

medicine for Parkinson's

diseaseNobutaka

Hattori

Asian Consortium

on MRI studies in Psychosis

projectKiyoto Kasai

Clinical Experience and Researches of Adult ADHD in

KoreaDuk-In Jon

Epignetic mechanisms underlying psychiatric disordersMakoto

Taniguchi

15:00 15:00

16:00 16:00

PosterDiscussion

17:00 17:00

18:00 18:00

Closing Ceremony

with Farewell Party

19:00 19:00

20:00 20:00

Luncheon SeminarTakeda Pharmaceutical Company

Limited / Lundbeck Japan K.K.

Luncheon SeminarMOCHIDA PHARMACEUTICAL CO., LTD. / Mitsubishi Tanabe Pharma Corporation /

Yoshitomiyakuhin Corporation

How should our journals be? ~ Clinical Psychopharmacology and Neuroscience &

Neuropsychopharmacology Reports ~

Duk-In JonTsuyoshi Miyakawa



J J

J

J E

J

E E

E

J

J E J

JJJ

E E

J J J E

E

E E E E

14:40

13:40

10:10

16:40

18:1018:20

12:30

8:20

13:30


Abstract Submission

Late-breaking Abstract Submission: July 1 (Mon) – 31 (Wed), 2019

Information

• Late-breaking abstracts will be published only on the website and will not be included in the abstract booklet.

• Presentation style for late-breaking abstracts is poster presentation only. (Late-breaking abstracts will not be selected for oral presentations.)

• First authors of late-breaking abstracts should be AsCNP members. Please see and check your AsCNP membership in the AsCNP homepage. When the first author is not an AsCNP member, please become an AsCNP member.

【AsCNP Homepage】http://ascnp.org/membership/index.html

• First authors of accepted abstracts should make a presentation in the poster sessions which are organized by chairs.

• First authors should be presenting authors and registered participants. Only abstracts submitted by first authors who have registered and paid their registration fees will be accepted.

Website Information

【AsCNP2019 Website】https://www2.aeplan.co.jp/ascnp/

【Hotel Reservation Website】https://www.tabikobo.com/corporate/mice/

ascnp2019/en/

【JSNP2019 Website】https://www2.aeplan.co.jp/jsnp/

【JSCNP2019 Website】https://www2.aeplan.co.jp/jscnp/



Registration

Registration Type

Rates

Early Bird *** Registration

January - July 31

Regular Registration

August 1 - August 30

On-site Registration

Members * JPY 37,000 JPY 40,000 JPY 45,000

Members(Developing Countries) **

JPY 22,000 JPY 25,000 JPY 30,000

Non-members JPY 47,000 JPY 50,000 JPY 55,000

Non-members(Developing Countries) **

JPY 32,000 JPY 35,000 JPY 40,000

Student Members JPY 8,000 JPY 10,000 JPY 15,000

Student Non-members JPY 11,000 JPY 13,000 JPY 18,000

Accompanying Persons JPY 5,000 JPY 5,000 JPY 5,000

Registration Fee for Members, Non-members and Student Members includes:

•Admission to all scientific sessions including Japanese sessions•Admission to Preopening Gathering on October 10 (Thu)•Admission to Opening Ceremony on October 11 (Fri)• Admission to the Joint Social Gathering with the Japanese Society of Neuropsychopharmacology

(JSNP) and the Japanese Society of Clinical Neuropsychopharmacology (JSCNP) on October 11 (Fri).

•Admission to poster exhibition and technical exhibition•Congress materials (Program Booklet, etc.)

Registration Fee for Accompanying Persons includes:

•Admission to Preopening Gathering on October 10 (Thu)•Admission to Opening Ceremony on October 11 (Fri)• Admission to the Joint Social Gathering with the Japanese Society of Neuropsychopharmacology

(JSNP) and the Japanese Society of Clinical Neuropsychopharmacology (JSCNP) on October 11 (Fri).

Registration Cancellation Policy

Registration fees are non-refundable.



Information of Certi�catesEach AsCNP2019 attendee receives the certificate of AsCNP2019 attendance

Information of certificates for Japanese attendees本大会では以下の制度の単位対象となっております（一部予定）。最新情報は JSNP2019または JSCNP2019大会ホームページをご確認ください。申請につきましては、参加証等必要書類を保管の上、各機関へ各自で申請手続きを行ってください。

日本神経学会　専門医制度単位数　大会参加にて 2単位

日本睡眠学会　睡眠医療認定単位数　大会参加にて 2単位

日本精神神経学会精神科専門医制度（予定）単位数　指定セッション聴講により最大 3単位（ポイント対象学会 B群）会期中に会員カードご提示により、所定の手続きをさせていただきますので、会員カードをご持参ください。

日本薬剤師研修センター　研修認定薬剤師制度（予定）単位数　3単位 /日（最大 9単位）日毎に受講シールを配布させていただきます。

日本病院薬剤師会　1）専門薬剤師・認定薬剤師（予定）単位数　指定セッション聴講により４単位 /日（最大

12単位）日毎に研修単位シールを配布させていただきます。

日本医師会　認定産業医制度（予定）単位数　指定セッション毎に 1単位産業医認定書番号（8桁）をお伺いし、認定シールを配布させていただきます。

2）精神科薬物療法認定薬剤師（予定）単位数　指定セッション毎に 0.75単位講習会受講書を配布させていただきます。申請時には日病薬研修単位シールもあわせて必要になります。

「日本薬剤師研修センター」の受講シールと「日本病院薬剤師会」の研修単位シールの重複発行はできません。

統合失調症薬物治療ガイドライン講習会統合失調症薬物治療ガイドラインに記載されている内容の周知だけでなく、記載されていないものの大切な問題についても紹介し、参加者が統合失調症について知識をより深めるものになることを目的としています。誰でも参加できますので、どなたでもご参加ください。事前参加申込者には、修了証をお渡しいたします。参加費：総会参加者：7,000円、本講習会のみの参加者：12,000円詳細は、JSNP2019及び JSCNP2019ホームページをご確認ください。

臨床精神神経薬理学セミナー臨床精神神経薬理学に関する優れた学識と高度の技術および倫理観を備えた臨床精神神経薬理学専門医を養成し、良質の医療を提供することを目的としています。

対　　象：日本臨床精神神経薬理学会会員・臨床精神神経薬理学専門医申請及び更新を

目指す医師の方・生涯学習の一環として受講を希望される方研修単位：専門医更新のための単位（10単位）受講料：臨床精神神経薬理学専門医 5,000円上記以外 10,000円

臨床試験 - 倫理教育セミナー精神神経用剤（向精神薬）の治療を適正に実施するために必要な基礎知識の普及を目的としています。

対　　象：日本臨床精神神経薬理学会会員研修単位：「治験登録医」、「創薬・育薬認定師」更新の

ための単位（4単位）受講料：5,000円

詳細は、JSCNP2019ホームページをご確認ください。


Access

1km

Tenjinkita

Gofukumachi

Chiyo-kenchoguchi

Higashi Park

Yoshizuka

Hako

zaki

Lin

e (F

ukuo

ka C

ity S

ubw

ay)

Nanotsu-dori

Taihaku-dori

SanyoShinkansen

Yoshizuka-dori

KagoshimaMain Line

Kag

osh

ima

Mai

n L

ine

Hotel New Otani

Watanabe-dori

Kokutai Doro

Nishitetsu Tenjin

Omuta Line

ANA CrownePlaza Fukuoka

Grand Hyatt

NishitetsuGrand Hotel

Kuko Line

(Fukuoka City Subway)

Nanakuma Line (Fukuoka City Subway)

Hotel Okura

Kyushu UniversitySchool of Medicine

KyushuShinkansen

Maidashi-Kyudai-byoin-mae

Gofukumachi

Nakasukawabata

AkasakaNishitetsuFukuoka Tenjin

Yakuin-Odori

Yakuin Watanabe-dori

Tenjinminami

Gion

Hakata Hyatt Regency

To FukuokaAirport

Tenjin

Chiyo

Hakataekihigasi

Chidoribashi JCT

Canal CityHakata

Hyaku

nenb

ashi

-dor

i

Fukuoka InternationalCongress Center

Fukuoka Sunpalace Hoteland Hall

Fukuoka International Congress Center / Fukuoka Sunplace Hotel and Hall

Fukuoka International Airport Fukuoka Airport Subway Station

Bus StopJR Hakata Station Hakata-exit City Bank-maeBus Stop FNo.88/ No.99

Bus StopTenjin Solaria Stage-mae Bus Stop2A No.80

【to Hakata Pier.】Get off at Kokusai Center-San Palace-mae

【to Chuou Pier.】Get off at Kokusai kaigijyo-San Palace-mae

No.88

5minutes.by subway

A short walk

11minutes.by busNo.99

15minutes.by subway

A short walk

9minutes.by busNo.80

ascnp - aeplan.co.jp · naoki nishiguchi toru nishikawa katsuji nishimura gentarou nishioka atsumi...

Documents